Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Jun;17(3):243-247.
doi: 10.1089/bio.2018.0080. Epub 2018 Dec 1.

Commentary on Improving Biospecimen Utilization by Classic Biobanks: Identifying Past and Minimizing Future Mistakes

William E Grizzle  1   2 , Katherine C Sexton  2
Affiliations

Commentary on Improving Biospecimen Utilization by Classic Biobanks: Identifying Past and Minimizing Future Mistakes

William E Grizzle et al. Biopreserv Biobank. 2019 Jun.

Abstract

Many classic biobanks collect more human tissues than they distribute, leading to increased inventories, unnecessary storage, increased expenses, and reduced chargeback income. This situation is a result of biobanks operating without well-defined goals, having incorrect views of the potential number of investigators who will utilize specimens, and collection of biospecimens without adequately considering the need for specific tissues by investigators. These deficiencies frequently lead to unrealistic plans for biospecimen utilization and biobanks that are larger than necessary. For example, tissue collections usually are not periodically compared with biospecimen distribution and modified accordingly. An ethical issue has arisen as to the acceptability of consenting patients for the use of their tissues in research without a realistic planned approach to distribution of the biospecimens and their ultimate utilization in supporting biomedical research. These issues and how to minimize them are discussed in this commentary focused on how classic biobanks can improve utilization of their biospecimens.

Keywords: biodistributor; biospecimens; classic biobank; research; utilization.

PubMed Disclaimer

Conflict of interest statement

No conflicting financial interests exist.

References

    1. Grizzle WE, Bell WC, Sexton KC. Issues in collecting, processing and storing human tissues and associated information to support biomedical research. In: Srivastava S, Grizzle WE. (eds). Translational Pathology of Early Cancer. Amsterdam: IOS Press BV; 2012: 531–549 - PMC - PubMed
    1. Henderson GE, Cadigan RJ, Edwards TP, et al. . Characterizing biobank organizations in the U.S.: Results from a national survey. Genome Med 2013;5:3. - PMC - PubMed
    1. iSpecimen, Inc. A worldwide study of the factors affecting sustainable biobanking operations and technology-based approaches to increase utilization rates: An independent survey. iSpecimen, Inc., Lexington, MA, May 2018. Available at: http://pages.ispecimen.com/Worldwide-Biobanking-Survey-Download.html
    1. Catchpoole D. Biohoarding: Treasures not seen, stories not told. J Health Serv Res Policy 2016;21:140–142 - PubMed
    1. Cardigan RJ, Lassiter D, Haldeman K, et al. Neglected ethical issues in biobank management: Results from a U.S. study. Life Sci Soc Policy 2013;9:1. - PMC - PubMed

LinkOut - more resources